Fouremm, 

I agree. Other news items are imminent too with most if not all of these slated for 2018. Publication of Medimmune xB3 collaboration/validation. Microdialysis pre-clinical results. NHP imaging study(s) for xB3-001. Start of clinical manufacturing of xB3-001. Pre-clinical mouse imaging studies with Minerva Imaging for xB3-002, and other proof of mechanism xB3-002 data. xB3-007 proof of mechanism studies. Lots to look forward to.

BearDownAZ